News
US FDA had inspected Aurobindo Pharma's Unit VII from May 2, 2022 to May 10, 2020 and had issued six observations.
Unit-VII is Aurobindo Pharma's oral manufacturing facility situated at Jedcherla, Hyderabad. It is ultra-modern unit based on the suite manufactu…
قراءة المزيد
News
USFDA closes warning letters for three sites of Dr Reddy's Laboratories | Pharma News
In November 2015, the company said it had received a warning letter from the US Food and Drug Administration (USFDA) for three of its sites -- acti…
قراءة المزيد
News
Dr Reddy's Labs Gets USFDA EIR For Srikakulam Formulations Plant | Pharma News
Hyderabad: Dr. Reddy's Laboratories Ltd on Wednesday said it has received an Establishment Inspection Report (EIR) from the US Food and Drug …
قراءة المزيد
Strides
USFDA clears four Indian manufacturing plants in 10 days | Pharma News
MUMBAI: India’s leading drug companies have had their manufacturing facilities cleared in the last 10 days by the US Food and Drug Administration (…
قراءة المزيد
News
FDA encourages recovered patients to donate plasma for development of blood-related therapies | Pharma News
As part of the all-of-America approach to fighting the COVID-19 pandemic, the U.S. Food and Drug Administration has been working with partners acr…
قراءة المزيد
News
FDA approves new treatments for heart disease caused by a serious rare disease, transthyretin mediated amyloidosis | Pharma News | FDA
On May 3, the U.S. Food and Drug Administration approved Vyndaqel (tafamidis meglumine) and Vyndamax (tafamidis) capsules for the treatment of the h…
قراءة المزيد
News
USFDA retains OAI status for Indoco's Goa plant | Pharma News | FDA
As per the USFDA, observations have been made after inspection of a facility in response to Form 483. An FDA Form 483 notifies the company's man…
قراءة المزيد
Social Plugin